Chemo-immunotherapy of advanced AIDS-related Kaposi's sarcoma

Tumori

Volumn 85, Issue 1, 1999, Pages 54-59

  Aversa, Savina Maria Luciana ^a   Cattelan, Anna Maria ^a   Salvagno, Luigi ^a   Meneghetti, Francesco ^a   Francavilla, Ermenegildo ^a   Sattin, Andrea ^a   Sasset, Lolita ^a   Cadrobbi, Paolo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

AIDS; Chemotherapy; Interferon; Kaposi's sarcoma

Indexed keywords

ANTIRETROVIRUS AGENT; BETA 2 MICROGLOBULIN; BLEOMYCIN; CD4 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; NEOPTERIN; RECOMBINANT ALPHA2B INTERFERON; VINBLASTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MALE; NEUTROPENIA; PROGNOSIS; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

EID: 0032967828     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169908500112     Document Type: Article

References (47)

1. Aversa S.M.L., Cattelan A.M., Salvagno L., Chiarion-Sileni V., Carretta M., Fiorentino M.: Treatment of HIV-associated Kaposi sarcoma. Proc. ASCO, 14: 291 (abstract 831), 1995.
2. Buchbinder A., Friedman-Kien A.: Clinical aspects of Kaposi's sarcoma. Curr. Opin. Oncol., 4: 867-847, 1992.
3. Center for Disease Control and Prevention: HIV/AIDS Surveillance Report, pp. 1-23, February 1993.
4. Center for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance of definition for AIDS among adolescents and adults. M.M.W.R.; 41: RR-17:1, 1992
5. Dupuy J., Price M., Lynch G., Bruce S., Schwartz M.: Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma. J. Am. Acad. Dermatol., 28: 966-972, 1993.
6. Epstein J.B., Scully C.: Intralesional vinblastine for oral Kaposi sarcoma in HIV infection. Lancet, 2: 1100-1101, 1989.
7. Fischl M.A., Uttamchandani R., Resnick L., Agarwal R., Fletcher M.A., Patrone-Reese J., Dearmas L., Chidekel J., McCann M., Myers M.: A phase I study of recombinant human interferon alpha 2a or human lymphoblastoid interferon alpha 1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J. Aids, 4: 1-10, 1991.
8. Fischl M.A., Krown S.E., Kevin P., Mitsuyasu R., Miles S., Wernz J.C., Volberding P.A., Kahn J., Groopman J.E., Feinberg J., Woody M., AIDS Clinical Trials Group: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J. Aids, 6: 259-264, 1993.
9. Gascon P., Schwartz R.: Treatment of Kaposi sarcoma. Current Therapy, 12: 451-456, 1994.
10. Gelmann E., Longo D., Lane N.C., Fauci A.S., Masur H., Wesley M., Preble O.T., Jacob J., Steis R.: Combination chemotherapy of disseminated Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Am. J. Med., 82: 456-462, 1987.
11. Gill P.S., Rarick M., Espina B., Loureiro C., Bernstein-Singer M., Akil B., Levine A.: Advanced acquired immunodeficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer, 65: 1074-1078, 1990.
12. Gill P.S., Rarick M.U., Bernstein-Singer M., Harb M., Espina B.M., Shaw V., Levine A.: Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am. J. Clin. Oncol., 13: 315-319, 1990.
13. Gill P., Rank M., McCutchan A., Slater L., Parker B., Mechmore E., Bernstein-Singer M., Akil B., Espina B., Krailo M., Levine A.: Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am. J. Med., 90: 427-433, 1991.
14. Gill P.S., Miles S.A., Mitsuyasu R.T., Montgomery T., McCarthy S., Espina B.M., Feldstein M., Levine A.M.: Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS, 8: 1695-1699, 1994.
15. Gill P.S., Rarick M.U., Bernstein-Singer M., Espina B.M., Jones B., Montgomery T., Sharma D., Rasheed S., Levine A.M.: Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J. Biol. Response, 9: 512-516, Mod 1990.
16. Goebel F.D., Goldestein D., Goos M., Jablonowski H. and Stewart J.S. for the International SL-Dox Study Group: Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Br. J. Cancer, 73: 989-994, 1996.
17. Gompels M.L., Hill A., Jenkins P., Peters B., Tomlison D., Harris J.R.W., Stewart S., Pinching A.J.: Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS, 6: 1175-1180, 1992.
18. Groopman J.E., Gottlieb M.S., Goodman J., Mitsuyasu R.T., Conant M.A., Price H., Fahey J.L., Derezin M., Weinstein W.M., Casavante C.: Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Ann. Intern. Med., 100: 671-676, 1984.
19. Kaplan E.L., Meier P.: Non parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
20. Kovacs J., Deyton L., Davey R., Falloon J., Zunich K., Lee D., Metcalf J., Bigley J., Sawyer L., Zoon K., Masur H., Fauci A., Lane C.: Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 11: 280-287, 1989.
21. Krown S.: Interferon and other biologic agents for the treatment of Kaposi's sarcoma. Hematol. Oncol. Clin. North America, 5: 311-322, 1991.
22. Krown S.E., Gold J., Niedzwiecki D., Bundow D., Flomenberg N., Gansbacher B., Brew B.: Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med., 112: 812-821, 1990.
23. Krown S.E., Metroka C., Wernz J.C.: Kaposi's sarcoma in the acquired immunodeficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J. Clin. Oncol., 7: 1201-1207, 1989.
24. Krown S.E., Real F., Vadhan Raj S., Cunningham Rundles S., Krim M., Wong G., Oettgen H.F.: Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer, 57 (8): 1662-1665, 1986.
25. Lane H.C., Kovacs J.A., Feinberg J., Herpin B., Davey V., Walker R., Deyton L., Metcalf J.A., Baseler M., Salzman N.: Antiretroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet, 2: 1218-1222, 1988.
26. Laubenstein L.J., Krigel R.L., Odajnyk C.M., Hymes K.B., Friedman-Kien A., Wernz J.C., Muggia F.M.: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastine. J. Clin. Oncol., 2: 1115-1120, 1984.
27. Lebbé C., Blum L., Pellet C., Blanchard G., Vérola O., Morel P., Danne O., Calvo F.: Clinical and biological impact of anti-retroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS, 12: F45-F49, 1998
28. Lipman M.C., Swaden L.S., Sabin C.A., Collis C., Johnson M.A.: Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS, 7: 592-593, 1993.
29. Minor D.R.: Vinblastine-methotrexate-vincristine chemotherapy for epidemic Kaposi's sarcoma. Proc. ASCO, 7: 9 (abstract 16), 1988.
30. Mintzer D., Real F.X., Jovino L., Krown S.: Treatment of Kaposi's sarcoma and thrombocytopenia in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med., 102: 200-202, 1985.
31. Mitsuyasu R.T.: Clinical variants and staging of Kaposi's sarcoma. Semin. Oncol., 14: 13-18, 1987.
32. Monfardini S., Tirelli U., Vaccher E.: Treatment of acquired immunodeficiency syndrome (AIDS)-related cancer. Cancer Treat. Rev., 20: 149-172, 1994.
33. Murphy M., Armstrong D., Sepkowitz K.A., Ahkami R.N., Myskowsky P.L.: Regression of AIDS-related Kaposi's sarcoma following treatment with an HIV-I protease inhibitor. AIDS, 11: 261-262, 1997.
34. Nakamura S., Sakurada S., Salahuddin Z., Osada Y., Tanaka N.G., Sakamoto N., Sekigughi M., Gallo R.: Inhibition of development of Kaposi's sarcoma-related lesions by bacterial cell wall complex. Science, 255: 1437-1440, 1992.
35. National Cancer Institute: Common Toxicity Criteria. National Cancer Istitute, Bethesda, MD, 1988.
36. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., Mc Fadden E.T., Carbone B.B.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol., 5: 649-655, 1982.
37. Orfanos C.E., Husak R., Wolfer U., Garbe C.: Kaposi's sarcoma: a reevaluation. Recent Results in Cancer Research, vol. 139, pp. 276-296, Springer-Verlag, Berlin-Heidelberg, 1995.
38. Pluda J., Broder S., Yarchoan R.: Therapy of AIDS and AIDS-associated neoplasms. In: Cancer Chemotherapy and Biological Response Modifiers Annual, Pinedo H.M., Longo D., Chabner B.A. (Eds.), vol. 13, pp. 1455-1463, Elsevier Science Publishers, Amsterdam, 1992.
39. Real F., Oettgen H.F., Krown S.E.: Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. J. Clin. Oncol., 4: 544-551, 1988.
40. Remick S.C., Reddy M., Herman D., Grace C., Harper G., Willis K., Candon B., Horton J., Ruckdeschel C.: Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. J. Clin. Oncol., 12: 1130-1136, 1994
41. Shields P., Dawkins F., Holmund J., Cohen P., Schulof R.: Weekly low-dose multidrug chemotherapy (MDCT) plus pneumocystis prophylaxis for HIV-related Kaposi's sarcoma (HIV-KS). Proc. ASCO, 8: 1 (abstract 1), 1989.
42. Sulis E., Floris C., Sulis M.I., Zurrida S., Pintus A., Contu L.: Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma. Eur. J. Cancer Clin. Oncol., 25: 759-761, 1989.
43. Tambussi G., Repetto L., Torri V., Saracco A., Moresco L., Antinori A., Zerboni R., Lazzarin A. (for GICAT), Badellino F.: Epidemic HIV-related Kaposi's sarcoma: a retrospective analysis and validation of TIS staging. Ann. Oncol., 5: 383-387, 1995.
44. Taylor J., Afrasiabi R., Fahey J.L., Korns E., Weaver M., Mitsuyasu R.: Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma. Blood, 67: 666-671, 1988.
45. Tulupe A., Joshi B., De Guzman N., Espina B.M., Mocharnuk R., Prakash O., Templeton D., Levine A.M., Gill P.S.: Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann. Oncol., 8: 79-83, 1997.
46. Volberding P., Abrams D., Conant M., Kaslow K., Vranizan K., Ziegler J.: Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Intern. Med., 103: 335-338, 1985.
47. Wernz J., Laubenstein L., Hymes K., Walsh C., Muggia F.: Chemotherapy and assessment of response in epidemic Kaposi's sarcoma (EKS) with bleomycin (B)/velban (V). Proc. ASCO, 5: 4 (abstract 15), 1988.